Publicacións nas que colabora con Ángel Díaz Lagares (21)

2024

  1. Biomarkers for Pre-Treatment Risk Stratification of Prostate Cancer Patients: A Systematic Review

    Cancers, Vol. 16, Núm. 7

  2. Evaluation of the clinical use of MGMT methylation in extracellular vesicle-based liquid biopsy as a tool for glioblastoma patient management

    Scientific Reports, Vol. 14, Núm. 1

  3. Genome-wide DNA methylation profiling in tongue squamous cell carcinoma

    Oral Diseases, Vol. 30, Núm. 2, pp. 259-271

2023

  1. Epigenomic reprogramming of therapy-resistant circulating tumor cells in colon cancer

    Frontiers in Cell and Developmental Biology, Vol. 11

  2. Somatic mutations in tumor and plasma of locoregional recurrent and/or metastatic head and neck cancer using a next-generation sequencing panel: A preliminary study

    Cancer Medicine, Vol. 12, Núm. 6, pp. 6615-6622

2022

  1. A genome-wide cell-free DNA methylation analysis identifies an episignature associated with metastatic luminal B breast cancer

    Frontiers in Cell and Developmental Biology, Vol. 10

  2. Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness

    Frontiers in Cell and Developmental Biology, Vol. 10

  3. Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA

    Clinical Epigenetics, Vol. 14, Núm. 1

2021

  1. Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non-small-cell lung cancer treated with pembrolizumab

    Molecular Oncology, Vol. 15, Núm. 11, pp. 2923-2940

  2. Epigenetic Landscape of Liquid Biopsy in Colorectal Cancer

    Frontiers in Cell and Developmental Biology, Vol. 9

  3. Evaluation of a targeted next-generation sequencing panel for the non-invasive detection of variants in circulating dna of colorectal cancer

    Journal of Clinical Medicine, Vol. 10, Núm. 19

  4. Modulation of colorectal tumor behavior via lncrna tp53tg1-lipidic nanosystem

    Pharmaceutics, Vol. 13, Núm. 9

  5. Salivary dna methylation as an epigenetic biomarker for head and neck cancer. Part i: A diagnostic accuracy meta-analysis

    Journal of Personalized Medicine, Vol. 11, Núm. 6

  6. Salivary dna methylation as an epigenetic biomarker for head and neck cancer. Part ii: A cancer risk meta-analysis

    Journal of Personalized Medicine, Vol. 11, Núm. 7

2020

  1. Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients

    Cells, Vol. 9, Núm. 2

  2. ZNF577 Methylation Levels in Leukocytes From Women With Breast Cancer Is Modulated by Adiposity, Menopausal State, and the Mediterranean Diet

    Frontiers in Endocrinology, Vol. 11

2019

  1. Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1

    Scientific Reports, Vol. 9, Núm. 1

  2. The role of clonal communication and heterogeneity in breast cancer

    BMC Cancer, Vol. 19, Núm. 1

2018

  1. Liquid Biopsy: From Basic Research to Clinical Practice

    Advances in Clinical Chemistry (Academic Press Inc.), pp. 73-119

2017

  1. Obesity and menopause modify the epigenomic profile of breast cancer

    Endocrine-related cancer, Vol. 24, Núm. 7, pp. 351-363